4.6 Letter

CD4+ T cells from patients with glucocorticoid-refractory immune thrombocytopenia have altered cytokine expression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia

Charlotte A. Bradbury et al.

Summary: In a multicenter, open-label, randomized trial on patients with immune thrombocytopenia, 91.5% of patients who received mycophenolate mofetil plus glucocorticoids had platelet levels above 100,000 per microliter, compared to 63.9% of patients who received glucocorticoids only. Quality-of-life measures of physical function and fatigue were worse in the mycophenolate mofetil group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Hematology

IL-10 and IL-17 expression by CD4+T cells is altered in corticosteroid refractory immune thrombocytopenia (ITP)

Madeleine L. Stimpson et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Multidisciplinary Sciences

Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A

Lauren P. Schewitz-Bowers et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Medicine, Research & Experimental

Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients

E Xystrakis et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)